Journal of Cancer Immunology & Therapy

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Cancer Immunology & Therapy 44 7897 074717

Cancer Scientific Journals

Cancer immunotherapy (therapy that uses an individual's system to fight cancer) has become a crucial field of oncology. There are four key kinds of immune-therapies: mono-clonal antibodies; cancer vaccines; check point inhibitors; and non-specific cancer immune-therapies (therapies that don't target cancer specifically, but stimulate immune cells that can cause anti-cancer immune reaction , like interleukins, cytokines, inter-ferons, and others). Tumors express ligands to immune checkpoint proteins, such as PD-1 (programmed cell death 1) and CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), mediating block of immune response. Thus, the development of inhibitors of these immune checkpoint pathways is a promising area of immune therapeutics. In addition, tumors express tumor antigens that can be targeted with antibodies; antibody-drug conjugates; chimeric antigen receptor (CAR) T cells; or by other approaches. Dendritic cell inoculation is additional significant immunotherapy method beside cancer. This Special Issue is focused on recent immunotherapy approaches, novel immune therapeutics, and immunology signaling pathways in cancer.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Immunology & Microbiology

Get the App